Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has issued an update.
ResMed Inc has announced a change in beneficial ownership involving its director, Ronald Taylor, who acquired 1,073 shares of ResMed common stock. This transaction reflects a strategic move in the company’s governance and may influence its market positioning, as it involves the vesting of Restricted Stock Units (RSUs) that will fully vest by November 2026 or at the next annual stockholders’ meeting.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$42.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc is a company operating in the healthcare industry, primarily focusing on the development and manufacturing of products for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions.
Average Trading Volume: 1,214,271
Technical Sentiment Signal: Buy
Current Market Cap: A$56.69B
See more data about RMD stock on TipRanks’ Stock Analysis page.